MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Evolution of Globus Pallidus Internus (GPi) Deep Brain Stimulation Targeting Over 15 Years

    V. Holanda, L. Almeida, M. Okun, A. Patterson, W. Deeb, A. Shukla, K. Foote (Gainesville, FL, USA)

    Objective: To evaluate the evolution of GPi DBS targeting over time in a large single center cohort. Background: Deep brain stimulation (DBS) targeting the globus…
  • 2017 International Congress

    Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

    F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)

    Objective: Conduct a comparative pharmacoeconomic analysis of the use of  subcutaneous apomorphine infusion pump (SAIP),   continuous levodopa/carbidopa duodenal infusión (LDI) and deep brain stimulation (DBS). Background:…
  • 2017 International Congress

    Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

    L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)

    Objective: To analyze the effect of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on cranial tremor in Parkinson’s disease (PD). Background: STN DBS…
  • 2017 International Congress

    Effects of deep brain stimulation on olfactory function in Parkinson’s disease

    R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff (São Paulo, Brazil)

    Objective: The aim of this prospective study was to assess the impact of deep brain stimulation (DBS) on olfactory function in Parkinson's disease (PD).  Background:…
  • 2017 International Congress

    Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation

    L. Deuel, J. Pilitsis, A. Ramirez-Zamora (Albany, NY, USA)

    Objective: To evaluate battery life in patients managed with unilateral or bilateral subthalamic nucleus (STN) interleaved deep brain stimulation (DBS) Background: DBS is a common…
  • 2017 International Congress

    Long term tremor benefit from cyst formation as a complication of DBS surgery in a patient with Parkinson’s disease

    P. Morrison, I. Richard (Rochester, NY, USA)

    Objective: To describe the unexpected, beneficial effects of cyst formation as a complication of sub-thalamic nucleus (STN) deep brain stimulation (DBS) surgery in a patient…
  • 2017 International Congress

    Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study

    K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, H. Fernandez (Washington, DC, USA)

    Objective: To evaluate the long-term safety/tolerability of deutetrabenazine (DTB) in patients with tardive dyskinesia (TD). Week 54 open-label results are reported in this interim analysis.…
  • 2017 International Congress

    Motor dysfunctions in rats following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin

    R. Shukla, R. Gupta, A. Pant, V. Khanna (Lucknow, India)

    Objective: To investigate the targets associated in regulating motor functions following subsequent exposure to stress on the neurotoxicity of lambda-cyhalothrin in rats. Background: Stress that…
  • 2017 International Congress

    Hemidystonia Associated with Alexander Disease

    D. Vijayakumar, R. Lewis, G. Fuller, S. Dhar, K. Machol, L. Robak, J. Jankovic (Houston, TX, USA)

    Objective: To describe an uncommon movement disorder phenotype of Alexander disease (AD). Background: AD is a rare autosomal dominant disorder that causes progressive leukodystrophy, especially…
  • 2017 International Congress

    Whole Exome Sequencing (WES) identifies a TUBB4A Mutation in two Saudi siblings with hypomyelinating leukodystrophy associated with atrophy of basal ganglia and cerebellum.

    Z. Aldaajani, E.-S. Ali (Dhahran, Saudi Arabia)

    Objective: To highlight the presentation of TUBB4A mutations. Background: Hypomyelinating leukodystrophy, identified in 2002 by magnetic resonance imaging is a rare heterogeneous group of diseases…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley